Salvivo Limited

Startup
Summarized by Halo AI

Salvivo Limited is a UK based health technology company building the global standard for dried saliva monitoring: a validated, paper-based platform for oral hydration assessment, standardised sample collection, and future multi-biomarker screening.

Founded & HQ
Newcastle upon Tyne, Tyne & Wear, England, UK
Company size
1-10 employees
IP status
1 grant confirmed
Activity highlights
Secured £99,080 in Innovate UK Analysis for Innovators funding to evaluate its FishburneTabs platform for biomarker detection with the National Physical Laboratory.

Our core product, FishburneTabs™, is a paper substrate device placed in the mouth for 30 seconds. It requires no equipment, no training, and no laboratory, saliva is absorbed into the paper, producing a visual readout or preserving the sample for downstream analysis. The platform is clinically validated, peer-reviewed, and already in active use in clinical trials.

We hold exclusive non-US commercial rights to the FishburneTabs platform, manufactured by our US partners FishburneMay LLC (USA). Our scientific work is underpinned by a government-funded metrological assessment partnership with the National Physical Laboratory (Innovate UK, 2026), a UK NIHR award, and by active engagement with an IHI EU oral health consortium.

Salvivo was founded by Dr Dale Athey and Professor Philip Preshaw, combining 30+ years of diagnostics commercialisation experience with 200+ publications in oral medicine and clinical research.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

DA
Dale Athey
Founder Director
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Sponsored researchCo-developmentLicensingEquity investmentPilot or trial engagement

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.